DEPARTMENT OF DEFENSE - CONGRESSIONALLY DIRECTED MEDICAL RESEARCH PROGRAMS

Synopsis of Current Program Funding Opportunities


FY20 Amyotrophic Lateral Sclerosis Research Program (ALSRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Therapeutic Development Award Program Announcement
Application Instructions
January 17, 2020
  • Maximum funding of $1.0 million for direct costs (plus indirect costs).
  • Maximum period of performance is 3 years.
Pre-Application: March 27, 2020

Preproposal is required; application submission is by invitation only.

Application: July 23, 2020
Therapeutic Idea Award Program Announcement
Application Instructions
January 17, 2020
  • Maximum funding of $500,000 for direct costs (plus indirect costs).
  • Maximum funding of $600,000 for direct costs plus indirect costs if applying for the Therapeutic Relevant Biomarker Option.
  • Maximum period of performance is 2 years.
Pre-Application: March 27, 2020

Preproposal is required; application submission is by invitation only.

Application: July 23, 2020
Clinical Development Award Program Announcement
Application Instructions
January 17, 2020
  • Maximum funding of $300,000 for direct costs (plus indirect costs).
  • Maximum period of performance is 2 years.
Pre-Application: March 27, 2020

Preproposal is required; application submission is by invitation only.

Application: July 23, 2020


FY20 Breast Cancer Research Program (BCRP)

Mechanism Program Announcement/Instructions Release Date Funding Amount Submission Deadline
Breakthrough Award Levels 1 and 2 Program Announcement
Application Instructions
December 23, 2019 Funding Level 1:
  • Maximum funding of $450,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 1 with Partnering PI Option:

  • Maximum funding of $750,000 for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 2:

  • Maximum funding of $1 million (M) for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 2 with Partnering PI Option:

  • Maximum funding of $1.5M for direct costs (plus indirect costs).
  • The maximum period of performance is 3 years.

Funding Level 2 – Population Science and Prevention Studies:

  • Maximum funding of $1.5M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.

Funding Level 2 – Population Science and Prevention Studies – Partnering PI Option:

  • Maximum funding of $2M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Letter of Intent): March 12, 2020

Application: March 26, 2020
Breakthrough Award Level 3 Program Announcement
Application Instructions
December 23, 2019 Funding Level 3:
  • Maximum funding of $3M in direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.

Funding Level 3 with Partnering PI Option:

  • Maximum funding of $4M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal): March 13, 2020

Invited Application:
June 24, 2020
Breakthrough Award Level 4 Program Announcement
Application Instructions
December 23, 2019 Funding Level 4 and Funding Level 4 with Partnering PI Option:
  • Maximum funding of $10M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal): March 13, 2020

Invited Application:
June 24, 2020
Era of Hope Scholar Award Program Announcement
Application Instructions
December 23, 2020
  • Maximum funding of $3M for direct costs (plus indirect costs).
  • The maximum period of performance is years.
Pre-Application (Letter of Intent): March 12, 2020

Application: March 26, 2020

Confidential Letters of Recommendation Submission Deadline: March 30, 2020
Innovator Award Program Announcement
Application Instructions
December 23, 2020
  • Maximum funding of $7M for direct costs (plus indirect costs).
  • The maximum period of performance is 4 years.
Pre-Application (Preproposal): March 13, 2020

Invited Application: June 24, 2020

Confidential Letters of Recommendation Submission Deadline: June 26, 2020






Last updated Friday, January 17, 2020